نتایج جستجو برای: aβ1

تعداد نتایج: 893  

2017
Junran Sun Peirong Huang Jian Liang Jie Li Mengxi Shen Xiangjun She Yiji Feng Xueting Luo Te Liu Xiaodong Sun

Amyloid-beta (Aβ) is a hallmark component of age-related macular degeneration (AMD), which induces secretion of pro-inflammatory cytokines from retinal pigment epithelium (RPE). Previous studies have shown that p50/RelA (p65), a member of NF-κB family, is an essential pro-inflammatory transcription factor responding to Aβ1-40 stimulation, but few focused on the other two Rel transcription facto...

2014
Guendalina Olivero Massimo Grilli Jiayang Chen Stefania Preda Elisa Mura Stefano Govoni Mario Marchi

Contradictory results have been reported on the interaction of beta-amyloid (Aβ) with cholinergic receptors. The present paper investigates the modulatory effect of Aβ1-40 on the neurotransmitter release evoked by nicotinic (nAChRs) and muscarinic (mAChRs) receptors. Aβ1-40 inhibits both nicotinic and muscarinic-evoked [(3)H]DA overflow from rat nerve endings. Added to perfusion medium, Aβ1-40 ...

2016
Chien-Li Chen Wen-Hao Tsai Chun-Jen Chen Tzu-Ming Pan

Centella asiatica ( léi gōng gēn) is a traditional medicinal herb with high antioxidant activity, which decreases amyloid-β (Aβ) deposition in the brain. At the same time, aggregated Aβ-induced oxidative stress is the trigger in the pathogenesis of Alzheimer's disease (AD). Here, we investigated the ability of C. asiatica ethanol extract (CAE) to protect PC12 and IMR32 cells from Aβ1-40-induced...

Journal: :Journal of Alzheimer's disease : JAD 2012
Rosa M Solano Maria J Casarejos Ana Gómez Juan Perucho Justo García de Yébenes Maria A Mena

Dementia occurs often in late stages of Parkinson's disease (PD) but its cause is unknown. Likewise there is little information about the interaction between proteins that produce PD and those implicated in Alzheimer's disease (AD). Here we have investigated the interactions between parkin protein and the amyloid-β (Aβ)1-42 peptide. We examined the effects of oligomeric Aβ1-42 peptide on the su...

Journal: :Neuropharmacology 2015
Gerhard Rammes Andreas Gravius Maarten Ruitenberg Nico Wegener Caroline Chambon Kamila Sroka-Saidi Ross Jeggo Lydia Staniaszek Dave Spanswick Eugene O'Hare Philip Palmer Eun-Mee Kim Wolfgang Bywalez Veronica Egger Christopher G Parsons

β-amyloid1-42 (Aβ1-42) is a major endogenous pathogen underlying the aetiology of Alzheimer's disease (AD). Recent evidence indicates that soluble Aβ oligomers, rather than plaques, are the major cause of synaptic dysfunction and neurodegeneration. Small molecules that suppress Aβ aggregation, reduce oligomer stability or promote off-pathway non-toxic oligomerization represent a promising alter...

2016
Bo Zhang-Haagen Ralf Biehl Luitgard Nagel-Steger Aurel Radulescu Dieter Richter Dieter Willbold Jie Zheng

Small proteins like amyloid beta (Aβ) monomers are related to neurodegenerative disorders by aggregation to insoluble fibrils. Small angle neutron scattering (SANS) is a nondestructive method to observe the aggregation process in solution. We show that SANS is able to resolve monomers of small molecular weight like Aβ for aggregation studies. We examine Aβ monomers after prolonged storing in d-...

Journal: :Journal of medicinal chemistry 2016
Julia Kaffy Dimitri Brinet Jean-Louis Soulier Isabelle Correia Nicolo Tonali Katia Fabiana Fera Yasmine Iacone Anaïs R F Hoffmann Lucie Khemtémourian Benoit Crousse Mark Taylor David Allsop Myriam Taverna Olivier Lequin Sandrine Ongeri

How anti-Alzheimer's drug candidates that reduce amyloid 1-42 peptide fibrillization interact with the most neurotoxic species is far from being understood. We report herein the capacity of sugar-based peptidomimetics to inhibit both Aβ1-42 early oligomerization and fibrillization. A wide range of bio- and physicochemical techniques, such as a new capillary electrophoresis method, nuclear magne...

2017
Ryan T. Cameron Ellanor Whiteley Jon P. Day Anna I. Parachikova George S. Baillie

Phosphodiesterase (PDE) inhibitors are currently under evaluation as agents that may facilitate the improvement of cognitive impairment associated with Alzheimer's disease. Our aim was to determine whether inhibitors of PDEs 4, 5 and 9 could alleviate the cytotoxic effects of amyloid beta 1-42 (Aβ1-42) via a mechanism involving the small heatshock protein HSP20. We show that inhibition of PDEs ...

2015
Josef Pannee

Alzheimer’s disease (AD) is the most common neurodegenerative disease among the elderly and accounts for 60-80% of all cases of dementia. Currently, the diagnosis of AD is based on cognitive tests and mental state exams, but the peptide amyloid-beta (Aβ) in cerebrospinal fluid (CSF) is increasingly used in clinical trials and settings. As for most protein and peptide biomarkers, quantification ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید